Researchers achieve remission using CAR-T Cell therapy for aggressive brain tumors

February 15, 2017 | Denise Heady

City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.

Continue Reading

Pediatric Clinical Trials

April 25, 2017 | City of Hope

Our team of clinical specialists and researchers are pioneering innovative treatments for pediatric cancer and childhood diseases, including advances in gene therapy, immunotherapy and targeted therapy.

Multiple Myeloma CAR-T Cell Trial to launch in 2017

April 3, 2017 | Travis Marshall

An upcoming phase 1 clinical trial at City of Hope will look at the effects of CAR-T cells programmed to target a protein called CS-1, which is found on myeloma cells.

2017 AACR: City of Hope scientists present new findings

April 1, 2017 | City of Hope

Studies address a variety of challenges in cancer treatment and research.

Research: Key Mechanism Found for Keeping Prostate Cancer at Bay

March 29, 2017 | Katie Neith

City of Hope scientists believe they have found a key mechanism for potentially keeping prostate cancer at bay, both before and after diagnosis.

Alpha Clinic Network: Experts Discuss Advancements in Stem Cell Therapies

March 28, 2017 | Michael Easterling

Patients who have benefited from stem cell therapies funded by CIRM were the focus of the second symposium of the Alpha Stem Cell Clinics Network.

Study: Stem Cell Transplants May Lead to Cure for Some T1D Patients

March 7, 2017 | Letisia Marquez

Clinical trial shows promising results from risky procedure, identifies path for personalized therapies. The results were published recently in the journal, Frontiers in Immunology.

Researchers achieve remission using CAR-T Cell therapy for aggressive brain tumors

February 15, 2017 | Denise Heady

City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR-T cells dramatically improved quality of life for patient with recurrent glioblastoma.

City of Hope Hosts Visiting Chinese Physicians

February 3, 2017 | Michael Easterling

As part of its Center for International Medicine (CIM) program, City of Hope recently hosted seven physicians from Renmin Hospital of Wuhan University, located the Hubei province of China.

Researchers tackle two difficult-to-treat lymphomas

February 2, 2017 | Letisia Marquez

New study in the Journal of Clinical Oncology concludes that patients with relapsed or treatment-resistant double-hit and/or double-expressor lymphomas didn’t respond as well to the transplantation as diffuse large B-cell lymphoma patients who did not have those types of lymphoma.

New Goal for Type 1 Diabetes Cure

January 16, 2017 | Letisia Marquez

A cure for Type 1 diabetes (T1D) in six years is the new goal of City of Hope’s Diabetes and Metabolism Research Institute. With more than $50 million in private funding, the institute will be able to lead an innovative research effort that seeks to find a cure for T1D.

Load More